CA2936914C - Method for separating target entities from a sample using a composition of mono-specific tetrameric antibody complexes coupled to a surface - Google Patents

Method for separating target entities from a sample using a composition of mono-specific tetrameric antibody complexes coupled to a surface Download PDF

Info

Publication number
CA2936914C
CA2936914C CA2936914A CA2936914A CA2936914C CA 2936914 C CA2936914 C CA 2936914C CA 2936914 A CA2936914 A CA 2936914A CA 2936914 A CA2936914 A CA 2936914A CA 2936914 C CA2936914 C CA 2936914C
Authority
CA
Canada
Prior art keywords
cells
tac
target entities
specific
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2936914A
Other languages
English (en)
French (fr)
Other versions
CA2936914A1 (en
Inventor
Andy Isamu KOKAJI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stemcell Technologies Canada Inc
Original Assignee
Stemcell Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemcell Technologies Inc filed Critical Stemcell Technologies Inc
Publication of CA2936914A1 publication Critical patent/CA2936914A1/en
Application granted granted Critical
Publication of CA2936914C publication Critical patent/CA2936914C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40Concentrating samples
    • G01N1/405Concentrating samples by adsorption or absorption
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA2936914A 2014-01-21 2015-01-21 Method for separating target entities from a sample using a composition of mono-specific tetrameric antibody complexes coupled to a surface Active CA2936914C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461929581P 2014-01-21 2014-01-21
US61/929,581 2014-01-21
PCT/CA2015/000036 WO2015109389A1 (en) 2014-01-21 2015-01-21 Method for separating target entities from a sample using a composition of mono-specific tetrameric antibody complexes coupled to a surface

Publications (2)

Publication Number Publication Date
CA2936914A1 CA2936914A1 (en) 2015-07-30
CA2936914C true CA2936914C (en) 2020-08-18

Family

ID=53544529

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2936914A Active CA2936914C (en) 2014-01-21 2015-01-21 Method for separating target entities from a sample using a composition of mono-specific tetrameric antibody complexes coupled to a surface

Country Status (8)

Country Link
US (1) US9970849B2 (https=)
EP (1) EP3097187B1 (https=)
JP (1) JP6694819B2 (https=)
CN (1) CN106414725B (https=)
BR (1) BR112016016740B1 (https=)
CA (1) CA2936914C (https=)
IL (1) IL246834B (https=)
WO (1) WO2015109389A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2946925C (en) * 2014-05-05 2023-08-15 Noviosmart Method for the serological diagnosis of rheumatoid arthritis.
CN107709366B (zh) 2015-06-10 2021-10-26 干细胞技术公司 用于双功能免疫复合物的原位形成的方法
WO2019232631A1 (en) * 2018-06-06 2019-12-12 Stemcell Technologies Canada Inc. Kits, compositions and methods for myeloid-derived suppressor cell enrichment
CN110514850B (zh) * 2019-07-23 2022-07-19 中国科学院苏州生物医学工程技术研究所 一种血型抗体复合物、制备方法
JP2023125973A (ja) * 2022-02-28 2023-09-07 シスメックス株式会社 測定試料の調製方法および試料調製装置
WO2024186904A2 (en) * 2023-03-06 2024-09-12 The Regents Of The University Of Colorado A Body Corporate Methods and compositions for functionalizing the surface of elastomeric particles

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230685A (en) 1979-02-28 1980-10-28 Northwestern University Method of magnetic separation of cells and the like, and microspheres for use therein
NL8501219A (nl) * 1985-04-29 1986-11-17 Stichting Vrienden Van De Stic Immunologisch complex, de bereiding en toepassing daarvan.
US6117985A (en) * 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US6008002A (en) * 1997-09-29 1999-12-28 Bodey; Bela Immunomagnetic detection and isolation of cancer cells
US7135335B2 (en) * 1999-05-28 2006-11-14 Stemcell Technologies Inc. Method for separating cells using immunorosettes
CA2375115C (en) 1999-05-28 2011-05-24 Stemcell Technologies Inc. Method for separating cells using immunorosettes
EP1227321A1 (en) 2000-12-28 2002-07-31 Institut für Bioanalytik GmbH Reversible MHC multimer staining for functional purification of antigen-specific T cells
IL158171A0 (en) * 2001-04-10 2004-03-28 Bioergonomics Inc Compositions and methods for cell separation
CA2411392C (en) * 2001-11-07 2012-10-16 Stemcell Technologies Inc. Tetrameric antibody complexes for blocking non-specific binding of antigens
US20060024824A1 (en) * 2004-07-16 2006-02-02 Steven Woodside Magnetic cell separation method
CA2559513A1 (en) * 2005-09-12 2007-03-12 Stemcell Technologies Inc. Modified colony assay
GB0616508D0 (en) * 2006-08-18 2006-09-27 Iti Scotland Ltd Analyte manipulation and detection
KR20130113476A (ko) * 2010-10-27 2013-10-15 ?티백트 에이/에스 인터칼레이터 (intercalator) 분자를 포함하는 프로브에 의한 표적 DNA 및 RNA의 캡쳐
ES2602500T3 (es) * 2011-11-25 2017-02-21 Miltenyi Biotec Gmbh Método de separación celular
ES2616289T3 (es) * 2012-03-01 2017-06-12 Miltenyi Biotec Gmbh Separación de neuronas vivas intactas
EP3594326B1 (en) * 2013-03-15 2023-11-15 Stemcell Technologies Inc. Method for separating cells using immunorosettes and particles
CN106687584B (zh) * 2014-09-04 2021-08-13 干细胞技术公司 用于t细胞或nk细胞活化和扩增的可溶性抗体复合物

Also Published As

Publication number Publication date
EP3097187A4 (en) 2017-01-25
JP2017504026A (ja) 2017-02-02
EP3097187A1 (en) 2016-11-30
CN106414725B (zh) 2020-12-18
US20150204765A1 (en) 2015-07-23
US9970849B2 (en) 2018-05-15
IL246834B (en) 2019-06-30
BR112016016740A2 (https=) 2017-08-08
CN106414725A (zh) 2017-02-15
JP6694819B2 (ja) 2020-05-20
CA2936914A1 (en) 2015-07-30
EP3097187B1 (en) 2018-07-04
WO2015109389A1 (en) 2015-07-30
IL246834A0 (en) 2016-08-31
BR112016016740B1 (pt) 2024-02-20

Similar Documents

Publication Publication Date Title
US11325984B2 (en) Method for separating cells using immunorosettes and magnetic particles
JP6126619B2 (ja) 細胞分離方法
US6117985A (en) Antibody compositions for preparing enriched cell preparations
CA2936914C (en) Method for separating target entities from a sample using a composition of mono-specific tetrameric antibody complexes coupled to a surface
AU769903B2 (en) Method for separating cells using immunorosettes
US6306575B1 (en) Methods for preparing enriched human hematopoietic cell preparations
CA2442577C (en) Cell separation compositions and methods
CN107709366B (zh) 用于双功能免疫复合物的原位形成的方法
US20020155511A1 (en) Novel antibody compositions for the negative selection of specific rat leukocyte subsets
CA2725132C (en) Method for separating cells using immunorosettes

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20200116

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - STANDARD

Year of fee payment: 10

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241213

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241213

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W200 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST OR RESPONSE SUBMITTED ONLINE

Effective date: 20250124

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251203

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251203